JPMA

Pharmaceutical Industry Associationjpma.or.jp

JPMA is a Japan-based pharmaceutical industry organization founded in 1968, headquartered in Chuo, that represents the pharmaceutical sector through research-based pharmaceutical products aimed at improving health and medical care.

Company typePrivate
Founded1999
HeadquartersChuo, Japan
Headcount11–50
GTM type—
OfferingServices

JPMA firmographics

Firmographics

Name: JPMA
Website: https://jpma.or.jp
Company type: Private
Founded year: 1999
Headcount range: 11–50 employees
Short description: JPMA is a Japan-based pharmaceutical industry organization founded in 1968, headquartered in Chuo, that represents the pharmaceutical sector through research-based pharmaceutical products aimed at improving health and medical care.
Ownership category
akta.pro rank

JPMA industry classification

Industry

Product category: Pharmaceutical Industry Association
NAICS: Pharmaceutical and Medicine Manufacturing (32541)
SIC: Services-Health Services (8000)
akta.pro primary industry: Access Policy, Advocacy & Stakeholder Management (HLAIAKAL)

Keywords

Pharmaceutical industry association
Drug research advocacy
Pharmaceutical manufacturers
Industry trade group
Pharmaceutical policy

Where JPMA is headquartered

Location

Headquarters

HQ city: Chuo
HQ country: Japan
HQ region: Asia

Markets served

JPMA product offering

Product offering

Core offering

JPMA represents the pharmaceutical industry through advocacy and policy engagement, promoting research-based pharmaceutical products that improve health and medical care. It serves as the collective industry voice for pharmaceutical manufacturers in Japan, focusing on enabling an environment that supports innovative drug development and patient access to medicines.

Differentiator

Problem solved

Functional benefit

Companies that use JPMA

Customer profile

Ideal customer profiles1 record

JPMA technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

JPMA competitors and assessment

Company assessment

Direct peers

IFPMA: The International Federation of Pharmaceutical Manufacturers and Associations is the global body representing the research-based pharmaceutical industry, of which JPMA is a national member association.
PhRMA: PhRMA is the US pharmaceutical industry association representing research-based biopharmaceutical companies. It is the most direct international counterpart to JPMA in mission, structure, and advocacy role.
ABPI: The Association of the British Pharmaceutical Industry is the UK's trade body for research-based pharma companies, structurally and functionally analogous to JPMA in Japan.
EFPIA: The European Federation of Pharmaceutical Industries and Associations represents the research-based pharmaceutical sector in Europe. It mirrors JPMA's role at the regional level for policy advocacy and stakeholder engagement.

Regional players

China Pharmaceutical Industry Association (CPIA): CPIA is the Chinese national pharmaceutical industry association. It serves a similar representative function to JPMA but in a different regulatory and market context in Asia.
Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA): KPBMA is the Korean pharmaceutical manufacturers association, representing a parallel research-based pharma industry in a neighboring Asian market. It is a relevant regional counterpart to JPMA rather than a direct competitor.
JAPIC (Japan Pharmaceutical Information Center): JAPIC is a Japanese healthcare information organization supporting pharmaceutical R&D and information dissemination. It operates in the same Japan ecosystem as JPMA but focuses on drug information rather than industry advocacy.
Federation of Pharmaceutical Manufacturers' Associations of Japan (FPMAJ): FPMAJ is a related Japanese pharmaceutical industry body, focused on distribution and pharmacy-related policy. It is a domestic counterpart to JPMA but addresses a different segment of the pharmaceutical value chain.

Others

Pharmaceuticals and Medical Devices Agency (PMDA): PMDA is Japan's regulatory agency for pharmaceuticals and medical devices. It is not a peer association but a key counterparty for JPMA's advocacy and policy work in Japan.

Broad incumbents

BIO (Biotechnology Innovation Organization): BIO represents the broader biotechnology industry in the US, including innovative pharmaceutical companies. It overlaps with JPMA's research-based innovation mandate but covers a wider technology and therapeutic scope.

Market position

Customer concentration

JPMA financial estimates

Financial estimate

Revenue estimate

Valuation estimate

JPMA leadership team

Management profile

Number of profiles

JPMA funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

JPMA M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JPMA

What does JPMA do?

When was JPMA founded?

JPMA was founded in 1999. It employs 11 to 50 people.

Where is JPMA based?

JPMA is headquartered in Chuo, Japan, in the Asia region.

Who are JPMA's main competitors?

Direct peers on record are IFPMA, PhRMA, ABPI and EFPIA. Regional players are China Pharmaceutical Industry Association (CPIA), Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), JAPIC (Japan Pharmaceutical Information Center) and Federation of Pharmaceutical Manufacturers' Associations of Japan (FPMAJ). Pharmaceuticals and Medical Devices Agency (PMDA) is listed as an others. BIO (Biotechnology Innovation Organization) is listed as a broad incumbent.

Does JPMA have an API?

No public API is recorded for JPMA.

What industry is JPMA in?

JPMA's product category is Pharmaceutical Industry Association. Its primary akta.pro industry code is HLAIAKAL, Access Policy, Advocacy & Stakeholder Management. Its NAICS code is 32541 and its SIC code is 8000.